Biosimilars
Bring your biosimilar to market faster by tapping into unparalleled data, technology, advanced analytics, and scientific expertise.


Report reveals varied physician views on biosimilars, highlighting access gaps, low familiarity in some groups, and the need for education and policy to boost adoption, using osteoporosis as a case study.
Bring your biosimilar to market faster by tapping into unparalleled data, technology, advanced analytics, and scientific expertise.
Patients with rheumatic disease often deal with chronic conditions impacting daily activities. The need for new therapies is high. Each clinical trial brings hope of effective disease management. Our experienced rheumatology team is here to support.